MFIII HP 230mg: The Best of Swiss Laboratories Dom AvMM
Now available in UV Protection Brown Bottle!


Receive FREE BONUS Royal Jelly Face Masks with every order of MFIII HP 230!
Properties of Human Placenta
Throughout a woman's pregnancy, the placenta plays a vital role to the baby. It has developed over millennia to ensure the health of the next generation of human beings. The placenta is an organ found only in mammals and supplies the baby with oxygen, nutrients, food, and protection, while being nurtured in the mother during pregnancy. Historically, some cultures have even practiced Placentophagy (or the consuming of placenta, after birth) to help the mother recover and to provide highly nutritious elements to her after the act of birth depleted her body of vital nutrients.
MFIII is hormone & protein-free! MFIII HP 230 will not add any artificial hormones to your body, which can affect natural hormone production. Since MFIII is protein-free, the risk of an allergic reaction is also minimal!
Recent scientific research has shown that human placenta contains rich growth factors, hormones, proteins, glycosaminoglycans, nucleic acids, polydeoxyribonucleotides (PDRNs), antibodies, and other concentrated nutrients that can rejuvenate organic tissue. It is rich in over 128 growth factors, including HGF, NGF, EGF, FGF, CFS, IGF-1, TGF, IL1, IL2, IL3 and IL4. Mitogenic actions of cytokines from placenta show an array of physiological effects, including anti-inflammatory properties, regulation of autonomous nerve systems, improvement of blood circulation, wound tissue healing, inhibition of protease, enhancement of nerve regeneration, balancing multiple hormone levels, immune boosting (anti-allergic), analgesic effects and the improvement of the intestinal environment.
MFIII Human Placenta is a safe, therapeutic agent with potent regenerating activities on all human tissue. When introduced into humans internally, it can reinforce deteriorating cells and hence bring back or restore their youth.
Composition and Safety of MFIII HP 230mg
MFIII of Switzerland's HP 230mg contains highly concentrated human placenta that is prepared using a patented high-tech extraction technology, utilizing ultra-filtration and cold method processing. Extraction is a common pharmaceutical technology used to isolate peptides, proteins, enzymes or cytokines, growth factors, hormones, and other compounds, which are essential substances for aging or ill organisms. The extraction and processing of tissue is done without denaturing heat sterilization, nor by utilizing any chemical additives. MFIII's advanced HP manufacturing method avoids the cheaper and more-destructive heat-based processing method of most other placenta-based products. Other inferior methods use temperatures of 125-180 degrees Celsius to sterilize human placenta, but this results in the damaging or destroying of many of the most effective elements found in the cells.
MFIII of Switzerland holds itself to the highest standards of safety and this begins from the very first step. Donors are pre-screened and placenta from eligible donors in the European Union are collected at Government-approved hospitals only. The placenta is then picked-up and delivered to the lab, within 24 hours of the birth. Donors suffering from communicable diseases, Hepatitis, HIV, Breech delivery, Twins birth, underweight birth, and burns are not considered. Furthermore, the donors and the placenta tissue are tested for Hepatitis, HIV and undergo ELISA testing.
Simply put, MFIII HP 230 mg is the most advanced Cell Therapy available at home. Although available in luxury anti-aging and wellness clinics for tens of thousands of dollars, this secret to youth and vitality is now available to everyone!
Back to Top
Benefits of MFIII HP 230mg
As a therapy for revitalization and rejuvenation, MFIII HP has a number of benefits, aside from managing the effects of aging.
Some of these benefits are:

-
Regenerates cells, tissues and organs
-
Increases flexibility in joints and discs
-
Strengthens the immune system against diseases
-
Improves alertness and mental awareness
-
Lightens facial pigmentation
-
Reduces facial pores and gives a glow to your skin
-
Enhances skin texture
-
Improves sleep patterns
-
Improves blood circulation, stamina and energy levels
-
Eliminates constipation
-
Decreases risk of heart disease
-
Relieves symptoms related to any chronic disease
-
Stabilizes weight to a normal level
-
Enhances your body shape and skin elasticity
Back to Top
Dosage & Usage
For a generally healthy person who is using MFIII HP230 for the purpose of anti-aging and disease prevention:
Start slowly at 3-5 day intervals for the first 5 injections, to allow time for the body to adjust. Then, dosage can be adjusted according to individual goals and reactions. 2-3 injections per week should be suitable for most people. We suggest no more than 6 injections a week - maximum.
For a person who has a particular ailment or injury:
Start slowly at 3-5 day intervals for first 5 injections, to allow time for the body to adjust. Depending on the individual, a complete 50-vial treatment with 3-6 injections per week, or even 2 vials every-other-day, is recommended. However, a higher dosage does not mean more effect or faster improvements, so careful observation of improvements should be made. For sensitive patients, reduce the number of treatments to 1 vial, with a few days in-between treatment and then build up again slowly. A repetition of the treatment cycle after 6 to 12 months is possible, depending on the illness and the individual patient's health. A subcutaneous or intramuscular injection on the Gluteal area with a thin needle should be given. We suggest no more than 6 injections a week - maximum.
Note: As with any injection, minor swelling may occur at the injection site on your skin. For quick relief in case of minor swelling, a cold compress (such as an ice pack or cold towel) may be applied to the area for no more than 15 minutes.
Back to Top
Swiss Certifications
MFIII is vigorously tested in independent Swiss laboratories and carries Swiss Certification number SCES002023. MFIII is manufactured and packed in the European Union, with full conformity to the following stringent international standards:
|
ISO9001 |
ISO14001 |
|
GMP (Good Manufacturing Practice) |
SQS (Swiss Association for Quality & Management System) |
|
TQM (Total Quality Management) |
SOP (Standard Operating Procedures) |
|
European Eurocerta Certifications |
GLP (Good Laboratory Practice) |
Back to Top
MFIII HP230 Versus "The Others"
Placenta in its fresh and purest native form - PURE FRESH BIO-ACTIVE!
MFIII HP230 is the world's only placenta by Cold Processed Extraction with proprietary Sterilization Technology, which does not involve any intense heat (as commonly done through pasteurization). It is best known for its general revitalisation, tissue and organs regeneration and overall rejuvenation with anti-aging demonstrated properties.
FEATURES
|
MFIII HP
|
OTHERS
|
|
Origin of Manufactured Product |
European Union
|
Questionable
|
|
Lab & Plant Certifications |
Yes
|
No
|
|
ISO 9001:20001 German Certification |
Yes
|
Mostly None
|
|
ISO 140001 German Certification |
Yes
|
Mostly None
|
|
IQNet Swiss Certification |
Yes
|
Mostly None
|
SQS Swiss Quality Management System in
development and manufacture of tissue culture
Certificate, Switzerland |
Yes
|
Mostly None
|
|
HACCP Certification, Germany |
Yes
|
Mostly None
|
|
Proprietary Cold-Processed Extraction |
Yes (one-of-its kind refrigeration process)
|
No. All via heating process
|
|
Fresh & Pure Extraction |
Yes
|
No
|
|
No chemicals, No preservatives |
Yes
|
No
|
Use of Intense heat during
pasteurization/sterilization process |
Absolutely No
|
Yes (125°C to180°C)
|
|
Native placental cells used |
Yes
|
No
|
Unique Microporosis ultra-filtration
sterillization |
Yes
|
No
|
GMP Pharmaceutical to European Union
stringent standards |
Yes
|
Mostly None
|
EU Certification of closed colony
(30 generations) |
Yes
|
None
|
|
'Milipore' USA Certification |
Yes
|
Mostly None
|
Support of Swiss Researchers & Cell Therapists
worldwide (Switzerland, Germany, Austria,
USA, South America, among others) |
Yes
|
None
|
Products endorsement by The International
Association for Cell Therapy (IACT),
Switzerland |
Yes
|
No
|
|
Brand Existence |
Yes (18 years)
|
Mostly 2 - 3 years
|
Storage & Transportation
Do not expose MFIII HP230 to heat or sunlight. Keep it out of the reach of children. It is best kept under refrigeration, but not freezing conditions. The shelf life for MFIII HP230 is 4 years, so expiration should not be a concern. Since it was designed with transportation in mind, as long as it is kept out of direct sunlight, the contents and efficacy will not be effected during shipment. In fact, it may be kept at room temperature for a few months.
FAQ
Please click here for our MFIII HP230 FAQ!
Research & Formulated by:
Lab Dom Avmm, Switzerland
Manufactured by:
Lab Dom Avmm, Switzerland
Note:
Does not come with syringes.
Orders of less than one box (50 vials) will be shipped in alternate packaging.
References
* Delves, P.J., Martin, S. J., Burton, D. R. and Roit I.M. Roitt's Essential Immunology (11th edition), Blackwell Publishing, 2006, ISBN 978-1-4051-3603-7.
* Ernst J. D. and Stendahl O., (editors), Phagocytosis of Bacteria and Bacterial Pathogenicity, Cambridge University Press, 2006, ISBN 0-521-84569-6 Website
* Hoffbrand, A.V., Pettit, J.E. and Moss, P.A.H., Essential Haematology (4th edition), Blackwell Science, 2005, ISBN 0-632-05153-1.
* Janeway, C.A., Murphy, K.M., Travers, P., Walport, M., Immunobiology (5th edition), Garland Science, New York, 2001. ISBN 0-8153-3642-X.
* Paoletti R., Notario A. and Ricevuti G., (editors), Phagocytes: Biology, Physiology, Pathology, and Pharmacotherapeutics, The New York Academy of Sciences, 1997, ISBN 1-57331-102-2.
* Robinson J.P. and Babcock G. F., (editors), Phagocyte Function —A guide for research and clinical evaluation, Wiley–Liss, 1998, ISBN 0471123641
* Sompayrac, L. How the Immune System Works (3rd edition), Blackwell Publishing, 2008, ISBN 978-1-4051-6221-0
*Mitchell, Richard Sheppard; Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson (2007). Robbins Basic Pathology. Philadelphia: Saunders. pp. 122. ISBN 1-4160-2973-7. 8th edition.
Back to Top